Tata Elxsi, SCTIMST sign MoU to advance healthcare innovation, MedTech development
Bengaluru, July 27
Tata Elxsi has signed a Memorandum of Understanding with Sree Chitra Tirunal Institute for Medical Sciences and Technology to boost healthcare innovation, as per a statement by the company.
As per the release, both the entities will address opportunities across diagnostics, medical imaging, digital health, biomedical engineering, medical devices, and related healthcare technologies for India and global markets.
"The MoU establishes a framework for joint research, academic engagement, technology development initiatives, and intellectual property creation through project-specific collaborations. Initial efforts are expected to focus on identifying a select set of high-potential opportunities for collaborative development," the release said.
SCTIMST is an Institution of National Importance under the Department of Science and Technology (DST), Government of India
As per the release, this partnership will establish an extended innovation and engineering ecosystem for Tata Elxsi, its customers and healthcare partners. It will bring together clinicians, specialist researchers, advanced laboratories, prototyping infrastructure and product engineering capabilities, to enable MedTech companies to develop, validate and scale new products more efficiently. It will also enhance capabilities in areas such as biocompatibility and toxicology.
Sreevatsa Sahasranaman, Senior Vice President and Head, Healthcare and Life Sciences, Tata Elxsi, said, "Healthcare innovation increasingly depends on closer collaboration between clinicians, scientists, and engineering teams. Our partnership with SCTIMST brings together complementary strengths across healthcare, technology, and product development to help address evolving healthcare needs. Recognised for its strong research and innovation capabilities, SCTIMST adds significant depth to this collaboration. We believe this partnership will help bring India-led innovation to global healthcare markets," as per the release.
The Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, is an Institution of National Importance under the Department of Science and Technology (DST), Government of India. Tata Elxsi is a global design and technology services company headquartered in Bangalore.
— ANI
Reader Comments
This is encouraging, but I hope the IP creation part doesn't end up making devices too expensive for common people. We already have so many imported machines in hospitals that cost a fortune. Fingers crossed for affordability!
As someone working in biotech, this partnership makes total sense. SCTIMST has done groundbreaking work in biomedical engineering but often lacks commercial scalability. Tata Elxsi brings that global product engineering expertise. Let's see some real MedTech unicorns from India! 💡
My father had a heart valve replacement and the device was from SCTIMST! It worked perfectly and cost much less than imported ones. With Tata's backing, we can make such quality devices accessible across all hospitals. This is the kind of Atmanirbhar Bharat we need – not just in defense but in healthcare too.
Finally, a collaboration that leverages India's clinical expertise and engineering talent together. The mention of 'extended innovation ecosystem' sounds promising. My only concern: will this also address mental health tech? Digital health should cover more than just imaging and diagnostics.
We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.